WALTHAM, MA—There is no doubt that diabetes has become a silent killer among Indians and South Asians. In an exclusive video interview with INE MultiMedia’s Health Talk series, Endocrinologist and Diabetologist Dr. Samir Malkani, MD, talks about diabetes, especially among Indians and South Asians.
During the upcoming Mega Health & Wellness Expo 2015 at Burlington Marriott Hotel in Burlington, MA, on April 19, Dr. Malkani, an Associate Clinical Professor of Medicine UMass Medical School in Worcester, MA, along with Dr. Om Ganda, MD, will speak on how to prevent and control diabetes. In this video interview Dr. Malkani talks about who should be afraid of diabetes and how it can be controlled with diet, exercise and medication.
“We have tried to fulfill our mission of educating the community about health issues since we started the annual free Health Expo in 2015. We have presented the best speakers at the Expo and interviewed them in INDIA New England News for a wider community outreach,” said Dr. Manju Sheth, President of INE MultiMedia and Chair of Mega Health & Wellness Expo 2015. “This year , we are excited to take it to the next level by launching Health Talk video series by INE MultiMedia leading up to the Health Expo in April. We hope that our viewers will appreciate this series and learn from our experts. We look forward to their feedback.”
Here are some basic facts about diabetes, featured in this Health Talk video.
• Diabetes is the 5th leading cause of death among Asian Americans.
• About 90 to 95 percent of Asians with diabetes have type 2 diabetes.
• South Asians have about 5 times the odds of having diabetes as U.S. born Caucasians.
• The Asian American population is more likely to have type 2 diabetes compared to non-Hispanic Whites despite having lower body weight.
• Asian American women suffer disproportionately from gestational diabetes (GDM).
Dr. Malkani is a board certified endocrinologist and diabetologist, who sees over 2000 patient visits for diabetes each year. He has an interest in clinical trials pertaining to the management of diabetes and its complications, and has been the Principal Investigator in many of these trials. He has participated in cardiovascular outcomes trials, drug trials for managing diabetes and its complications, and trials related to the use of technology in diabetes.
